1?,25-Dihydroxyvitamin D3-3?-(2)-bromoacetate, an affinity labeling derivative of 1?,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells-Reference-Cited by-同舟云学术

1?,25-Dihydroxyvitamin D3-3?-(2)-bromoacetate, an affinity labeling derivative of 1?,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells

Published:2003-07-16 Issue:5 Volume:89 Page:909-916
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Swamy Narasimha,Persons Kelly S.,Chen Tai C.,Ray Rahul

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference29 articles.

1. Vitamin D and Prostate Cancer

2. Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-21

3. Mechanistic Studies to Evaluate the Enhanced Antiproliferation of Human Keratinocytes by 1α,25-Dihydroxyvitamin D3–3-bromoacetate, a Covalent Modifier of Vitamin D Receptor, Compared to 1α,25-Dihydroxyvitamin D3

4. Affinity labeling of the nuclear vitamin D receptor with nonsteroidal alkylating agents

5. The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers;Oncotarget;2016-02-17

2. 1,25-dihydroxyvitamin D3-3-bromoacetate, a novel vitamin D analog induces immunosuppression through PI3K/Akt/mTOR signaling cascade;International Immunopharmacology;2013-11

3. 1α,25-Dihydroxyvitamin-D3-3-Bromoacetate Regulates AKT/mTOR Signaling Cascades: A Therapeutic Agent for Psoriasis;Journal of Investigative Dermatology;2013-06

4. 1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: Synthesis and molecular mechanism of action;Bioorganic & Medicinal Chemistry Letters;2011-04

5. A Vitamin D Receptor-Alkylating Derivative of 1α,25-Dihydroxyvitamin D3 Inhibits Growth of Human Kidney Cancer Cells and Suppresses Tumor Growth;Cancer Prevention Research;2010-12